Zoubir Ouhib1, Michael Kasper2, Jose Perez Calatayud3, Silvia Rodriguez4, Ajay Bhatnagar5, Sujatha Pai6, John Strasswimmer7. 1. Department of Radiation Oncology, Lynn Cancer Institute, Boca Raton, FL. Electronic address: Zouhib@brrh.com. 2. Department of Radiation Oncology, Lynn Cancer Institute, Boca Raton, FL. 3. Department of Radiation Oncology, Hospital La Fe, Valencia, Spain; Department of Radiation Oncology, Hospital Clinica Benidorm, Alicante, Spain. 4. Department of Radiation Oncology, Hospital Clinica Benidorm, Alicante, Spain. 5. Department of Radiation Oncology, 21st Century Oncology Inc., Casa Grande, Arizona. 6. Department of Radiation Oncology, Targeted Radiation Therapy Institute, Pleasanton, CA. 7. Department of Biochemistry, Florida Atlantic University College of Medicine, Boca Raton, FL; Department of Dermatology, Florida Atlantic University College of Medicine, Boca Raton, FL.
Abstract
PURPOSE: Nonmelanoma skin cancers (NMSCs) are the most common type of human malignancy. Although surgical techniques are the standard treatment, radiation therapy using photons, electrons, and brachytherapy (BT) (radionuclide-based and electronic) has been an important mode of treatment in specific clinical situations. The purpose of this work is to provide a clinical and dosimetric summary of the use of BT for the treatment of NMSC and to describe the different BT approaches used in treating cutaneous malignancies. METHODS AND MATERIALS: A group of experts from the fields of radiation oncology, medical physics, and dermatology, who specialize in managing cutaneous malignancies reviewed the literature and compiled their clinical experience regarding the clinical and dosimetric aspects of skin BT. RESULTS: A dosimetric and clinical review of both high dose rate ((192)Ir) and electronic BT treatment including surface, interstitial, and custom mold applicators is given. Patient evaluation tools such as staging, imaging, and patient selection criteria are discussed. Guidelines for clinical and dosimetric planning, appropriate margin delineation, and applicator selection are suggested. Dose prescription and dose fractionation schedules, as well as prescription depth are discussed. Commissioning and quality assurance requirements are also outlined. CONCLUSIONS: Given the limited published data for skin BT, this article is a summary of the limited literature and best practices currently in use for the treatment of NMSC.
PURPOSE:Nonmelanoma skin cancers (NMSCs) are the most common type of humanmalignancy. Although surgical techniques are the standard treatment, radiation therapy using photons, electrons, and brachytherapy (BT) (radionuclide-based and electronic) has been an important mode of treatment in specific clinical situations. The purpose of this work is to provide a clinical and dosimetric summary of the use of BT for the treatment of NMSC and to describe the different BT approaches used in treating cutaneous malignancies. METHODS AND MATERIALS: A group of experts from the fields of radiation oncology, medical physics, and dermatology, who specialize in managing cutaneous malignancies reviewed the literature and compiled their clinical experience regarding the clinical and dosimetric aspects of skin BT. RESULTS: A dosimetric and clinical review of both high dose rate ((192)Ir) and electronic BT treatment including surface, interstitial, and custom mold applicators is given. Patient evaluation tools such as staging, imaging, and patient selection criteria are discussed. Guidelines for clinical and dosimetric planning, appropriate margin delineation, and applicator selection are suggested. Dose prescription and dose fractionation schedules, as well as prescription depth are discussed. Commissioning and quality assurance requirements are also outlined. CONCLUSIONS: Given the limited published data for skin BT, this article is a summary of the limited literature and best practices currently in use for the treatment of NMSC.
Authors: S Rodríguez; M Arenas; C Gutierrez; J Richart; J Perez-Calatayud; F Celada; M Santos; A Rovirosa Journal: Clin Transl Oncol Date: 2017-08-14 Impact factor: 3.405
Authors: Anna O Likhacheva; Phillip M Devlin; Shervin M Shirvani; Christopher A Barker; Phillip Beron; Ajay Bhatnagar; Stephen W Doggett; Lawrence Hochman; Charles Hsu; Michael Kasper; Martin Keisch; Subhakar Mutyala; Bradley Prestidge; Silvia Rodriguez Villalba; Vershalee Shukla; Srinath Sundararaman; Mitchell Kamrava Journal: Brachytherapy Date: 2016-11-28 Impact factor: 2.362
Authors: Sofian Benkhaled; Dirk Van Gestel; Carolina Gomes da Silveira Cauduro; Samuel Palumbo; Veronique Del Marmol; Antoine Desmet Journal: Front Med (Lausanne) Date: 2022-06-27
Authors: Rosa Ballester-Sánchez; Olga Pons-Llanas; Cristian Candela-Juan; Francisco Javier Celada-Álvarez; Christopher A Barker; Alejandro Tormo-Micó; Jose Pérez-Calatayud; Rafael Botella-Estrada Journal: J Contemp Brachytherapy Date: 2016-01-28